Jupiter, FL, United States of America

Kevin Eduard Hauser

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Eduard Hauser: Innovator in Engineered Polypeptides

Introduction

Kevin Eduard Hauser is a notable inventor based in Jupiter, Florida. He has made significant contributions to the field of biotechnology, particularly in the design and application of engineered polypeptides. With a total of two patents to his name, Hauser's work is at the forefront of innovative protein modeling techniques.

Latest Patents

Hauser's latest patents include "Engineered CD25 polypeptides and uses thereof." This patent provides engineered polypeptides that incorporate spatially-associated topological constraints derived from a CD25 reference target. The methods outlined in this patent include using these engineered polypeptides as positive and/or negative selection molecules in screening libraries of binding molecules, such as antibodies. Another significant patent is "Machine learning method for protein modelling to design engineered peptides." This patent describes methods for designing engineered polypeptides that replicate molecular structure features of predetermined portions of reference protein structures. The process involves training a machine learning model to generate blueprint records that lead to the creation of engineered polypeptides.

Career Highlights

Kevin Eduard Hauser is currently associated with Ibio Limited, where he applies his expertise in biotechnology and protein engineering. His innovative approaches have positioned him as a key player in the development of advanced therapeutic solutions.

Collaborations

Hauser collaborates with talented individuals in his field, including Matthew Paul Greving and Alexander T Taguchi. These collaborations enhance the research and development efforts at Ibio Limited, fostering a creative environment for innovation.

Conclusion

Kevin Eduard Hauser's contributions to the field of engineered polypeptides exemplify the intersection of biotechnology and machine learning. His patents reflect a commitment to advancing scientific knowledge and developing practical applications that can benefit various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…